Preparation, in vitro release, in vivo absorption and biocompatibility studies of insulin-loaded microspheres in rabbits

AAPS PharmSciTech

Volumn 6, Issue 3, 2005, Pages

  Kang, Feirong ^a,b   Singh, Jagdish ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Biocompatibility; In vivo absorption; Insulin; Microspheres; PLGA

Indexed keywords

BIOMATERIAL; MICROSPHERE; POLYGLACTIN; RECOMBINANT HUMAN INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SYNTHESIS; DRUG TISSUE LEVEL; EMULSION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PHYSICAL CHEMISTRY; RABBIT; SINGLE DRUG DOSE;

EID: 27744496506     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/pt060361     Document Type: Article

References (16)

1. Steil CF. Diatetes mellitus. In: DiPiro JT, Talbert RL, Yee GC, eds. Pharmacotherapy: A pathophysiologic approach. 4th ed. Stamford, CT: Appleton & Lange; 1999:1219-1243.
2. Galloway JA, Chance RE. Improving insulin therapy: achievements and challenges. Horm Metab Res. 1994;26:591-598.
3. White J, Campbell RD. Diabetes mellitus. In: Herfindal ET, Gourly DR, eds. Textbook of therapeutics: drug and disease management. Baltimore, MD: Williams & Wilkins; 1996:357-386.
4. Riddle MC. Timely initiation of basal insulin. Am J Med. 2004;116:3S-9S.
5. LeRoith D, Levetan CS, Hirsch IB, Riddle MC. Type 2 diabetes: the role of basal insulin therapy. J Fam Pract. 2004;53:215-222.
6. Jiang G, Qiu W, DeLuca PP. Preparation and in vitro/in vivo evaluation of insulin-loaded poly(acryloylhydroxyethyl starch)-PLGA composite microspheres. Pharm Res. 2003;20:452-459.
7. Ziats NP, Miller KM, Anderson JM. In vitro and in vivo interactions of cells with biomaterials. Biomaterials. 1988;9:5-13.
8. Athanasiou KA, Niederauer GG, Agrawal CM. Sterilization, toxicity, biocompatibility and clinical application of polylactic acid/ polyglycolic acid copolymers. Biomaterials. 1996;17:93-102
9. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28:5-24.
10. Pariente JL, Kim BS, Atala A. In vitro biocompatibility assessment of naturally derived and synthetic biomaterials using normal human urothelial cells. J Biomed Mater Res. 2001;55:33-39.
11. Ike O, Shimizu Y, Wada R, Hyon SH, Ikada Y. Controlled cisplatin delivery system using poly(D,L-lactic acid). Biomaterials. 1992;13:230-234.
12. Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76-85.
13. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969;22:158-161.
14. Morgan CR, Lazarow A. Immunoassay of insulin using a two-antibody system. Proc Soc Exp Biol Med. 1962;110:29-32.
15. Ravivarapu HB, Burton K, DeLuca PP. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. Eur J Pharm Biopharm. 2000;50:263-270.
16. Takenaga M, Yamaguchi Y, Kitagawa A, Ogawa Y, Mizushima Y, Igarashi R. A novel insulin formulation can keep providing steady levels of insulin for much longer periods in-vivo. J Pharm Pharmacol. 2002;54:1189-1194.